C11ORF84 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.263600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.214000E-01
Normal-vs-Stage2
4.353400E-01
Normal-vs-Stage3
5.771600E-01
Normal-vs-Stage4
3.998000E-01
Stage1-vs-Stage2
3.518600E-01
Stage1-vs-Stage3
5.369800E-01
Stage1-vs-Stage4
4.794800E-01
Stage2-vs-Stage3
1.127190E-01
Stage2-vs-Stage4
8.572600E-01
Stage3-vs-Stage4
2.361000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.307000E-01
Normal-vs-AfricanAmerican
4.365600E-01
Normal-vs-Asian
3.914400E-01
Caucasian-vs-AfricanAmerican
7.536800E-01
Caucasian-vs-Asian
9.805000E-01
AfricanAmerican-vs-Asian
7.401000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.093600E-01
Normal-vs-Female
4.424800E-01
Male-vs-Female
7.713600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.536820E-01
Normal-vs-Age(41-60Yrs)
1.187790E-01
Normal-vs-Age(61-80Yrs)
5.940600E-01
Normal-vs-Age(81-100Yrs)
9.730000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.952800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.941000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.432960E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.542500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.559600E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.366000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.233800E-01
Normal-vs-Daily Drinker
3.600800E-01
Normal-vs-Weekly Drinker
2.678600E-01
Normal-vs-Occasional Drinker
1.537220E-01
Normal-vs-Social Drinker
2.554400E-01
Non Drinker-vs-Daily Drinker
2.252800E-01
Non Drinker-vs-Weekly Drinker
5.133900E-02
Non Drinker-vs-Occasional Drinker
1.348210E-02
Non Drinker-vs-Social Drinker
7.713800E-02
Daily Drinker-vs-Weekly Drinker
2.713800E-01
Daily Drinker-vs-Occasional Drinker
1.252570E-01
Daily Drinker-vs-Social Drinker
4.021200E-01
Weekly Drinker-vs-Occasional Drinker
8.385800E-01
Weekly Drinker-vs-Social Drinker
7.694400E-01
Occasional Drinker-vs-Social Drinker
5.726600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.655600E-01
Normal-vs-Grade 2
9.465800E-01
Normal-vs-Grade 3
9.874400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.197400E-01
Grade 1-vs-Grade 3
6.989000E-01
Grade 1-vs-Grade 4
9.655600E-01
Grade 2-vs-Grade 3
2.680800E-01
Grade 2-vs-Grade 4
9.465800E-01
Grade 3-vs-Grade 4
9.874400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.232200E-01
Normal-vs-NonDiabetic
3.463400E-01
Diabetic-vs-NonDiabetic
3.264800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.348500E-02
Normal-vs-NoPancreatitis
4.521400E-01
Pancreatitis-vs-NoPancreatitis
7.685000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.944000E-01
Normal-vs-N1
4.331400E-01
N0-vs-N1
9.693200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.695400E-01
Normal-vs-TP53-NonMutant
8.732000E-01
TP53-Mutant-vs-TP53-NonMutant
5.180400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
